Several cancer treatments cause cardiotoxicity that can lead to heart failure, coronary artery disease, arrhythmia, and pericardial

 

Abstract

Several cancer treatments cause cardiotoxicity that can lead to heart failure, coronary artery disease, arrhythmia, and pericardial disease. In this review, representative cases of heart failure following cardiotoxicity caused by trastuzumab, anthracycline, and hematopoietic stem cell transplantation are described with case notes. Additionally, other important points regarding cardiotoxicity related to heart failure are reported. During and after potentially cardiotoxic therapy, periodic cardiac examinations are recommended to detect any cardiovascular disorders; these are ameliorated if appropriately diagnosed at an earlier stage. It is important for cardiologists and oncologists to understand the pathophysiology of representative cardiovascular disease cases following cancer treatment.

PMID: 32143767 [PubMed - as supplied by publisher]

9 March 2020

12:40

Cancer & Heart (Cardio-Oncology, Cardiotoxicity, TEV)

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

12:40

In reply to this message

pubmed: caandvteortroorpul

Failure to extubate and delayed reintubation in elective lumbar fusion: An analysis of 57,677 cases.

Related Articles

Failure to extubate and delayed reintubation in elective lumbar fusion: An analysis of 57,677 cases.

Clin Neurol Neurosurg. 2020 Mar 02;193:105771

Authors: Gelfand Y, Longo M, De la Garza Ramos R, Sharfman ZT, Echt M, Hamad M, Kinon M, Yassari R, Kramer DC